These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15842640)

  • 1. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
    Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
    Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
    Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?
    Marioni G; Giacomelli L; D'Alessandro E; Marchese-Ragona R; Staffieri C; Ferraro SM; Staffieri A; Blandamura S
    Am J Otolaryngol; 2008; 29(3):156-62. PubMed ID: 18439947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
    Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin expression in oral squamous cell carcinoma.
    Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
    J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
    Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
    Maass N; Hojo T; Ueding M; Lüttges J; Klöppel G; Jonat W; Nagasaki K
    Clin Cancer Res; 2001 Apr; 7(4):812-7. PubMed ID: 11309327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
    He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.
    Sopel M; Surowiak P; Berdowska I
    Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
    Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
    Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
    McConnell DT; Miller ID; Parkin DE; Murray GI
    Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.
    Xia W; Lau YK; Hu MC; Li L; Johnston DA; Sheng Sj; El-Naggar A; Hung MC
    Oncogene; 2000 May; 19(20):2398-403. PubMed ID: 10828881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
    Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
    Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.